Cleared Traditional

K083509 - LIFEGLOBAL HUMAN SERUM ALBUMIN LG HSA

K083509 is the FDA 510(k) clearance for LIFEGLOBAL HUMAN SERUM ALBUMIN LG HSA by Intl., Inc.. It is a Class 2 Obstetrics & Gynecology device (product code MQL) cleared through the Traditional 510(k) pathway after a 149-day FDA review.

K083509 · Intl., Inc. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
149d
Days
Class 2
Risk

K083509 is an FDA 510(k) clearance for the LIFEGLOBAL HUMAN SERUM ALBUMIN LG HSA. Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by <Genx> Intl., Inc. (Gilford, US). The FDA issued a Cleared decision on April 24, 2009 after a review of 149 days - within the typical 510(k) review window.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Intl., Inc. devices

Submission Details

510(k) Number K083509 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 26, 2008
Decision Date April 24, 2009
Days to Decision 149 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Statement
Third-party Review No - reviewed directly by FDA
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 160d · This submission: 149d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Peers - MQL Media, Reproductive

All 141
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K083509.
GLOBAL DMSO BLASTOCYST VITRIFICATION KIT AND WARMING KIT
K092667 · Intl., Inc. · Jun 2010
LIFEGLOBAL PROTEIN SUPPLEMENT
K092578 · Intl., Inc. · Apr 2010
VIT KIT - FREEZE AND THAW
K093273 · Irvine Scientific Sales Co., Inc. · Mar 2010
RAPIDVIT AND RAPIDWARM CLEAVE
K080446 · Vitrolife Sweden AB · Nov 2008
G-MOPS G5 SERIES
K081115 · Vitrolife Sweden AB · Sep 2008
G-1 V5
K081114 · Vitrolife Sweden AB · Sep 2008